Research Peptides · Alpha BioMed Partnership
Peptide Solutions Connecting Science, Quality & Opportunity
JJV Bio connects research professionals and businesses with peptide research solutions, quality documentation, educational resources, and brand development opportunities through our partnership with Alpha BioMed.

Featured Research Partner
Alpha BioMed
JJV Bio partners with Alpha BioMed and serves as your direct point of contact — from first research product inquiry to documentation, account coordination and white label programs.
Research product inquiries
A single JJV Bio contact for questions about available research peptides.
Documentation
Coordination of available quality documentation for specific products and lots.
Account coordination
Guidance through account setup and ongoing communication.
White label
Facilitation of branded and private label research peptide programs.
Research Portfolio
Explore Research Peptides
Research-use-only products are intended for laboratory and analytical research — not for human or veterinary administration. Product availability and pricing are provided through consultation.
Individual Peptides
A range of individual research peptides for laboratory and analytical research.
Specialized Research Formulations
Research formulations available for qualified inquiries.
Quality Documentation
Lot-specific Certificates of Analysis where available.
Scientific Resources
Background literature and educational materials on peptide science.

Brand Development
White Label & Private Label Solutions
Alpha BioMed offers white labeling, and JJV Bio facilitates the process — helping you build branded research peptide products with confidence.
Branded Research Peptide Products
Develop research peptide products under your own brand.
Custom Labeling & Packaging
Explore labeling and packaging options for your program.
Portfolio Development
Plan a focused research product portfolio aligned with your business.
Coordination
JJV Bio coordinates communication from first inquiry through fulfillment.
Available options, minimum order quantities (MOQs) and timelines are subject to confirmation.

Documentation
Research Quality Matters
Quality documentation helps researchers evaluate materials. Available documentation varies by product and lot.
Lot-Specific COAs
Certificates of Analysis tied to individual production lots, where available.
HPLC Testing Information
High-performance liquid chromatography purity information, where available for a given product.
Mass Spectrometry Information
Identity confirmation data, where available for a given product.
Professional Support
JJV Bio helps you locate and interpret the documentation available for your inquiry.
Not every product includes every test. Confirm available documentation for a specific product and lot with JJV Bio.
Education
Education & Professional Resources
JJV Bio supports research professionals with educational materials on peptide science and the regulatory landscape.
Educational resources and available dosing-related documentation can be discussed upon request.
Research Literature
Curated peer-reviewed publications on peptide biology and chemistry.
Scientific Resources
Background materials on peptide structure, synthesis and characterization.
Available Training
Professional training opportunities, as available.
Science & Regulatory Developments
Updates on peptide research and the evolving regulatory landscape.
From Scientific Research to FDA-Approved Medicines
Peptide science has contributed to several prescription medicines that were separately reviewed and approved by the FDA for specific indications. Examples include:
- Semaglutide
- Ozempic® · Wegovy® · Rybelsus®
- Tirzepatide
- Mounjaro® · Zepbound®
- Liraglutide
- Victoza® · Saxenda®
- Dulaglutide
- Trulicity®
- Teriparatide
- Forteo®
FDA approval is specific to each prescription drug product and its approved indications. It does not apply to research peptides, research-use-only products, or any product in the Alpha BioMed catalog. Brand names are trademarks of their respective owners.
Regulatory Update · October 28, 2026
HHS Interim Enforcement-Discretion Policy
On October 28, 2026, HHS issued an interim policy describing conditional enforcement discretion for qualifying pharmacy compounding involving the following peptides:
- BPC-157
- TB-500
- KPV
- MOTS-c
- Epitalon
- Semax
This policy is narrow and conditional. It is not FDA approval of these substances, makes no determination of safety or effectiveness, and does not permit human use of research-use-only materials. Consult the official document and qualified regulatory counsel for specifics.
Read the official HHS policy (PDF)FAQ
Frequently asked questions
What educational resources does JJV Bio provide?
JJV Bio can share research literature, scientific background materials, information on available training, and updates on peptide science and regulatory developments. Request educational resources by scheduling a consultation.
Does JJV Bio offer white label or private label peptides?
Yes. Through our partnership with Alpha BioMed, which offers white labeling, JJV Bio facilitates branded research peptide products, custom labeling and packaging options, and portfolio development. Available options, minimum order quantities and timelines are subject to confirmation.
How do I access research products?
Schedule a consultation with JJV Bio. We discuss your research needs, coordinate account setup and serve as your direct point of contact. Products are not ordered through this website.
Are Certificates of Analysis available?
Lot-specific Certificates of Analysis are available where provided for a given product and lot. HPLC and mass spectrometry information may be available for specific products; not every product includes every test. JJV Bio can help you confirm what documentation exists for your inquiry.
How do I inquire about wholesale pricing?
Pricing is not published on this website. Wholesale and volume pricing inquiries are handled individually — schedule a consultation to discuss your needs.
Are all peptides FDA-approved?
No. Certain peptide-based prescription drugs, such as semaglutide or teriparatide, have been approved by the FDA for specific indications. That approval applies only to each specific prescription drug product and indication. It does not apply to research peptides or to any product in the Alpha BioMed catalog, which are intended for research use only.
What does the October 2026 HHS policy mean?
HHS announced an interim enforcement-discretion policy concerning certain peptides (BPC-157, TB-500, KPV, MOTS-c, epitalon and semax) in the context of qualifying pharmacy compounding under specific conditions. It is not FDA approval of these substances and does not permit human use of research-use-only materials. Consult the official policy document and qualified regulatory counsel for details.
Explore Peptide Solutions With JJV Bio
Connect with JJV Bio to discuss research products, documentation, white label opportunities and educational resources.
Research Use Only. Research peptides are intended solely for laboratory and analytical research and are not for human or veterinary administration, diagnosis, treatment, cure or prevention of any disease. They are not FDA-approved. JJV Bio does not provide dosing or administration guidance. Information on this page is educational.
Regulatory note. Products in this portfolio do not share a single regulatory status, and some are not FDA-approved or cleared. Product-specific regulatory information must be reviewed before any marketing use. Nothing on this site is a claim of safety, efficacy, or suitability for any indication.